The Controversy Surrounding Hippocratic AI’s Latest Funding

Hippocratic AI's recent $137 million funding sparks controversy over whether investing heavily in AI startups is the best use of capital amid pressing healthcare needs.
Hippocratic AI, a startup aiming to revolutionize healthcare through generative artificial intelligence (AI), recently announced an extension of its Series A funding round, bringing the total investment to $137 million. The company welcomed new investors, including NVentures—the venture capital arm of NVIDIA—Greycroft, and Lee Shapiro of 7Wire Ventures. This marks one of NVentures' first non-biotech healthcare investments, signaling a significant shift in venture capital interest towards AI-driven healthcare solutions. While the infusion of capital underscores the growing confidence in AI's potential to transform healthcare, it has also ignited a heated debate. Critics question whether pouring such substantial funds into AI startups like Hippocratic AI is the most effective way to a
Subscribe or log in to Continue Reading

Uncompromising innovation. Timeless influence. Your support powers the future of independent tech journalism.

Already have an account? Sign In.

📣 Want to advertise in AIM Media House? Book here >

Picture of 재은
재은
AIM is the world's leading media and analyst firm dedicated to advancements and innovations in Artificial Intelligence. Reach out to us at info@aimmediahouse.com
25 July 2025 | 583 Park Avenue, New York
The Biggest Exclusive Gathering of CDOs & AI Leaders In United States

Subscribe to our Newsletter: AIM Research’s most stimulating intellectual contributions on matters molding the future of AI and Data.